跳至主要内容
临床试验/IRCT20200506047323N8
IRCT20200506047323N8尚未招募2 期

Evaluation of the effects of epinephrine on the treatment of COVID-19 pneumonia: a randomized clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 months(—)
性别
All

入选标准

  • Age between 18 and 80 years
  • Positive polymerase chain reaction (PCR) test for COVID-19
  • Hospitalized
  • Signing informed consent and willingness of study participant to accept randomization to any assigned treatment a

排除标准

  • Contraindications epinephrine including, hemorrhagic CVA, TIA, and acute MI
  • Heart rate > 100
  • History of allergy to epinephrine
  • Pregnancy and breastfeeding

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验